Concise monthly summaries of peer-reviewed biomedical research.
Each month we process hundreds of papers per topic to highlight what actually matters, saving you time! Topic requests welcome.
www.summarized.science
🩸 Liquid Biopsy - Feb 2026
• Urine biopsies detect minimal residual disease in bladder cancer
• Pan-cancer analysis identifies 14,202 methylation regions for cancer detection
• Multi-omics integration boosts sensitivity in the PROMISE study
• M-PACT classifies pediatric CNS tumors from low-input cfDNA
• High ctDNA tumor fraction linked to worse survival in germ cell tumors
• Hyaluronan mediates CTC clustering in triple-negative breast cancer
🦠 Melanoma - Feb 2026
• Personalized mRNA vaccine shows durable reduction in melanoma recurrence
• HOXD13 regulates angiogenesis and immune evasion in melanoma
• Pepyrus boosts sensitivity in HLA-bound neoantigen discovery
• SITC defines consensus criteria for ICI resistance
• Vibostolimab adds no benefit over pembrolizumab alone in melanoma
• Pathologic response assessment shows high reproducibility across tumor types
✂️ Gene Editing - Feb 2026
• LUMI-lab synthesizes 1,700+ LNPs with 20% gene editing efficacy in lung cells
• Protein2PAM boosts Cas9 PAM cleavage rates 50-fold
• AAVLINK enables full-length protein expression beyond AAV packaging limits
• Fusion peptides improve mRNA delivery and editing outcomes in vivo
• Transgene-free strigolactone receptor editing confers viral resistance in rice
• GRAPE-LM evolves RNA aptamers in a single screening round
🧫 Microglia - Feb 2026
• IL-10 variant boosts neurogenesis and cognition in aged mice
• RIPK1 inhibition blocks pro-inflammatory drivers of Alzheimer
• BTK inhibition reduces neuroinflammation in ALS models
• Distinct epigenomic subtypes reveal unique microglial signatures in Alzheimer's
• Microglia-T cell interactions drive neurodegeneration in Huntington's
• TGF-β inhibition in microglia stimulates adult neurogenesis
🔬 Spatial Transcriptomics - Feb 2026
• CLIM-TIME maps 7 TME subtypes linked to T cell therapy response
• Kupffer cells promote immune evasion in liver metastases
• CD276 drives chemoresistance in pancreatic cancer
• T cell activation correlates with better survival in glioblastoma
• mFISH3D visualizes multiple mRNA types in intact mouse brains
• RNA-modifying proteins emerge as potential therapeutic targets
🫧 Extracellular Vesicles - Feb 2026
• NE+ EVs drive chronic inflammation and emphysema in COPD
• LipoFB-derived EVs restore lung cell function in COPD
• TIGIT in myeloid cells linked to immunosuppression in glioblastoma
• Mitochondrial transfer via EVs boosts glioblastoma resistance
• RORγ-enriched exosomes alleviate diabetic kidney injury
• EVs play key roles in metabolic regulation and disease
💉 GLP-1 Agonists - Feb 2026
• GLP-1RAs reduce heart failure risk vs DPP-4 inhibitors
• GLP-1RAs linked to optic neuropathy risk in younger patients
• Semaglutide shows chondroprotective effects in osteoarthritis
• Tirzepatide cuts major cardiovascular events vs placebo
• Income barriers affect semaglutide prescription uptake
• Semaglutide improves post-ablation outcomes in atrial fibrillation
🧠 Meningioma - Feb 2026
• Tumor microenvironment challenges traditional meningioma classification
• CDKN2A/B deletions linked to worse prognosis
• KMT2C loss drives NF2-wildtype progression via ferroptosis sensitivity
• Seizure-causing meningiomas show distinct molecular features
• Progestogen use raises intracranial meningioma risk
• Y chromosome loss tied to higher tumor grades in males
🧬 Bioinformatics - Feb 2026
• Microbial dispersal and gene flow identified as key drivers of microbiome structure
• 22-protein panel distinguishes multiple sclerosis from other inflammatory diseases
• LUMI-lab autonomously synthesized 1,700+ lipid nanoparticles for mRNA delivery
• 134 mutational signatures identified across 16 cancer types
• Improved polygenic risk scores for breast cancer in African-ancestry women
🧬 Extracellular Vesicles — Jan 2026
• Inhalable and engineered EVs overcome immunotherapy resistance
• EV-derived miRNAs reprogram macrophage phenotypes in cancer
• Regenerative applications expand in cardiac, cartilage, and tendon repair
🧠 Meningioma — Jan 2026
• Targeted therapies show mixed results in NF2-mutant disease
• Epigenetic loss (H3K27me3) refines recurrence risk
• AI imaging and intraoperative tools enhance classification and decision-making
🧠 Neuro-Oncology — Jan 2026
• Spatial multi-omics reveals microenvironmental niches in glioma
• Germline risk variants refine glioma susceptibility
• CD47 destabilization and macrophage subsets expand immunotherapy angles
• Epigenetic drivers and local therapeutic platforms target recurrence
🧠 Alzheimer Microglia — Jan 2026
• Distinct microglial states emerge with disease-specific gene programs
• TREM2 and metabolic wiring shape microglial function in AD
• Environmental and infectious signals modulate neuroinflammation
• Exosomes, miRNAs, and Aβ disaggregation explored as therapeutic angles
🩸 Diabetes — Jan 2026
• AI models improve continuous glucose prediction
• GLP-1/GIP and SGLT2 therapies expand cardiometabolic impact
• Genetic diversity and care disparities shape disease outcomes
• Structural insights refine understanding of T2D pathogenesis
🧬 Tumor Microenvironment — Jan 2026
• Engineered CAR-T and TAM targeting reshape local immunity
• Fibroblast checkpoints and macrophage signaling drive resistance
• DNA sensing and pyroptosis pathways amplify immunotherapy response
• Population-scale modeling refines immune stratification
#TumorMicroenvironment #CancerImmunology #Immunotherapy #TAMs #Biology
🧫 Stem Cells — Jan 2026
• Developmental origin shapes fibroblast function and scarring
• Stem and stromal plasticity influence tumor immunity
• Metabolic stress impairs intestinal stem cell repair
• Organoids and engineered niches enhance lineage modeling and engraftment
🎗️ Melanoma — Recent Research
• Long-term survival improves with neoadjuvant checkpoint blockade
• Targeted therapy benefits linked to mutation burden
• CRISPR screens and toxicity insights refine immunotherapy strategy
🧪 Liquid Biopsy — Jan 2026
• Post-treatment ctDNA predicts recurrence across multiple cancers
• Baseline mutation status refines prognosis in advanced disease
• CTCs and EV-derived signals guide therapy response
🧠 Microglia — Jan 2026
• TREM2 and metabolic rewiring influence neurodegeneration
• Infectious and inflammatory triggers amplify CNS immune signaling
• Microglia-targeted therapies gain momentum in neurodegenerative disease
📊 Bioinformatics - Jan 2025
• Population-scale modeling maps the tumor immune microenvironment
• RNA–small molecule prediction advances structure-free drug discovery
• Improved microbiome analytics refine association testing